Day: July 1, 2025

PRESS RELEASEJuly 1, 2025Evolution of the accounting treatment of Renault Group’s stake in NissanRenault Group’s stake in Nissan, which was previously accounted for under the equity method, will be treated as a financial asset measured at fair value through equity, estimated on the basis of Nissan’s stock price, as of June 30, 2025. This approach aligns the value of the stake in Nissan in Renault Group’s financial statements with the value of Nissan’s share price. The financial impact, which is non-cash and has no impact on the calculation of the dividend paid by Renault Group, is estimated at a loss of €9.5 billion1, recognized in the income statement, mostly in other operating income and expenses as of June 30, 2025. The operational projects and collaboration resulting from the strategic...

Press Release dsm-firmenich announces redemption of €750 million hybrid bond Kaiseraugst (Switzerland), Maastricht (Netherlands), July 1, 2025 dsm-firmenich, innovators in nutrition, health, and beauty, has decided to call and redeem the €750 million Deeply Subordinated Fixed Rate Resettable Perpetual Loan Notes (the “hybrid bond”) issued on May 27, 2020 (XS2182055009) by Firmenich International SA (the “Issuer”), a direct subsidiary of DSM-Firmenich A.G. The €750 million hybrid bond, with a coupon of 3.75%, is treated as equity under IFRS rules. The Issuer is exercising its right to call and redeem the €750 million hybrid bond at 100 percent of its nominal value plus accrued interest on August 5. Formal notice of redemption in accordance with the terms and conditions of the hybrid bond has been given separately. For more information,...

Issy-les-Moulineaux, July 1, 2025 (7am)Sodexo (Euronext Paris FR 0000121220-OTC: SDXAY)Organic revenue growth of +3.0% Fiscal 2025 expected to land at the lower end of the guidance range:Organic revenue growth between +3% and +4% Underlying operating profit margin improvement between +10 and +20 bps, at constant currenciesQ3 FISCAL 2025 REVENUESREVENUES(in million euros) Q3 FY25 Q3 FY24   ORGANICGROWTH EXTERNALGROWTH CURRENCYEFFECT TOTALGROWTHNorth America 2,873 2,904   +1.2% +0.1% -2.4% -1.1%Europe 2,176 2,096   +3.3% +0.0% +0.5% +3.8%Rest of the World 1,072 1,074   +7.5% -1.2% -6.5% -0.2%TOTAL 6,121 6,074   +3.0% -0.2% -2.1% +0.8%Commenting on the third quarter activity, Sophie Bellon, Sodexo Chairwoman and CEO, said: “Our third quarter organic growth is in line with expectations and reflects the continuation...

34,611 vehicles delivered in June, up 224% YoY Achieved a new record quarterly deliveries of 103,181 units in Q2 2025 First-half 2025 deliveries hit 197,189 units, surpassing total deliveries in 2024 30,000+ monthly deliveries sustained for eight consecutive monthsGUANGZHOU, China, July 01, 2025 (GLOBE NEWSWIRE) — XPeng Inc. (“XPENG” or the “Company,” NYSE: XPEV and HKEX: 9868), a leading Chinese smart electric vehicle (“Smart EV”) company, today announced its vehicle delivery results for June and the first half of 2025. In June 2025, XPENG delivered 34,611 Smart EVs, representing a year-over-year increase of 224% and marking the eighth consecutive month that deliveries exceeded 30,000 units. In the second quarter of 2025, XPENG delivered 103,181 Smart EVs, setting a new quarterly record. This brings XPENG’s total deliveries...

SAN JOSE, Calif., June 30, 2025 (GLOBE NEWSWIRE) — Zscaler, Inc. (Nasdaq: ZS) today announced the pricing of $1.5 billion aggregate principal amount of 0.00% convertible senior notes due 2028 (the “notes”) in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Zscaler also granted the initial purchasers of the notes a 13-day option to purchase up to an additional $225 million aggregate principal amount of notes. The offering is expected to close on July 3, 2025, subject to customary closing conditions. The notes will be senior unsecured obligations of Zscaler. The notes will not bear regular interest and the principal amount of the notes will not accrete. The notes will mature on July 15, 2028, unless earlier...

PERTH, Australia, July 01, 2025 (GLOBE NEWSWIRE) — Canyon Resources Limited (ASX: CAY) (‘Canyon’ or the ‘Company’) is pleased to announce that Mr Peter Secker has officially commenced his role as Chief Executive Officer (CEO), effective 1 July 2025. Canyon announced the leadership transition for Mr Secker and former CEO Mr Jean Sebastien Boutet on February 5, 2025, when Peter joined the Company as a strategic advisor. During this time, Peter has played an instrumental role in supporting the management team and Board, with a focus on optimising the development schedule for the flagship Minim Martap Bauxite Project (‘Minim Martap’ or ‘the Project’), helping advance and secure key regulatory approvals, finalise the Company’s strategic stake in CAMRAIL and progress funding initiatives to place the Company in a strong position to start...

Combined Company Expected to be Listed on NASDAQ Global MarketDRC Medicine Ltd. (“DRC Medicine” or the “Company”), is an innovative healthcare and biotechnology company headquartered in Japan, focused on the research, development, and commercialization of advanced medical technologies that address significant global health challenges. The Company is best known for its proprietary Hydro Silver Titanium® technology, initially applied in consumer hygiene products such as masks and towels, and now being advanced to obtain medical device certification as among the world’s first therapeutic masks for seasonal allergic rhinitis. Combined company to have an implied initial pro forma equity value of approximately $422.15 Million, (assuming no redemptions) and the transaction is expected to deliver cash proceeds of around $50.42 Million to...

VANCOUVER, British Columbia, June 30, 2025 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSXV: RKV) (the “Company”) announces that it will apply to the TSX Venture Exchange (the “Exchange”) to amend the terms of certain outstanding warrants and convertible debentures of the Company, as further described herein. Convertible Debenture Amendments The Company intends to file an application with the Exchange to amend the terms of its 12.0% unsecured convertible debentures with an outstanding aggregate principal amount of $1,454,000.00 (the “Convertible Debentures”) issued pursuant to the Company’s non-brokered private placement of Convertible Debenture units closed on May 29, 2023 (the “Debenture Unit Private Placement”). The Convertible Debentures are governed by an indenture dated May 29, 2023 (the “Indenture”) between the Company...

WALTHAM, Mass., June 30, 2025 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced the pricing of an underwritten public offering of 24,242,425 shares of its common stock at a public offering price of $8.25 per share. The gross proceeds to Dyne from the offering, before deducting underwriting discounts and commissions and offering expenses payable by Dyne, are expected to be $200.0 million. All shares in the offering are being sold by Dyne. The offering is expected to close on or about July 2, 2025, subject to customary closing conditions. In addition, Dyne has granted the underwriters a 30-day option to purchase up to an additional 3,636,363 shares of its common stock at the...

CALGARY, Alberta, June 30, 2025 (GLOBE NEWSWIRE) — Acceleware® Ltd. (“Acceleware” or the “Company”) (TSX-V: AXE), a leading innovator of cutting-edge radio frequency (“RF”) power-to-heat technologies targeting process heat for critical minerals, amine regeneration (for carbon capture and other applications), and enhanced oil production, is pleased to announce a non-brokered private placement of units of the Company (the “Units”), at a price of $0.10 per Unit (the “Unit Price”), for gross proceeds of up to $1,500,000 (the “Private Placement”). Details of the Private Placement Pursuant to the Private Placement, each Unit will consist of (i) one (1) common share in the capital of the Company (a “Common Share”); and (ii) one (1) Common Share purchase warrant of the Company (a “Warrant”). Each Warrant will entitle the holder thereof...